Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies
- PMID: 28314823
- PMCID: PMC5380577
- DOI: 10.1158/1055-9965.EPI-16-0796
Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies
Abstract
Background: There are few established risk factors for gallbladder cancer beyond gallstones. Recent studies suggest a higher risk with high body mass index (BMI), an indicator of general heaviness, but evidence from other body size measures is lacking.Methods: Associations of adult BMI, young adult BMI, height, adult weight gain, waist circumference (WC), waist-height ratio (WHtR), hip circumference (HC), and waist-hip ratio (WHR) with gallbladder cancer risk were evaluated. Individual-level data from 1,878,801 participants in 19 prospective cohort studies (14 studies had circumference measures) were harmonized and included in this analysis. Multivariable Cox proportional hazards regression estimated hazard ratios (HR) and 95% confidence intervals (CI).Results: After enrollment, 567 gallbladder cancer cases were identified during 20.1 million person-years of observation, including 361 cases with WC measures. Higher adult BMI (per 5 kg/m2, HR: 1.24; 95% CI, 1.13-1.35), young adult BMI (per 5 kg/m2, HR: 1.12; 95% CI, 1.00-1.26), adult weight gain (per 5 kg, HR: 1.07; 95% CI, 1.02-1.12), height (per 5 cm, HR: 1.10; 95% CI, 1.03-1.17), WC (per 5 cm, HR: 1.09; 95% CI, 1.02-1.17), WHtR (per 0.1 unit, HR: 1.24; 95% CI, 1.00-1.54), and HC (per 5 cm, HR: 1.13; 95% CI, 1.04-1.22), but not WHR (per 0.1 unit, HR: 1.03; 95% CI, 0.87-1.22), were associated with higher risks of gallbladder cancer, and results did not differ meaningfully by sex or other demographic/lifestyle factors.Conclusions: These findings indicate that measures of overall and central excess body weight are associated with higher gallbladder cancer risks.Impact: Excess body weight is an important, and potentially preventable, gallbladder cancer risk factor. Cancer Epidemiol Biomarkers Prev; 26(4); 597-606. ©2017 AACR.
©2017 American Association for Cancer Research.
Figures


References
-
- Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Jan 14, 2014. [website]
-
- American Cancer Society. Cancer Treatment and Survivorship Facts & Figures 2014–2015. Atlanta, GA: American Cancer Society; 2014.
-
- Coe PO, O’Reilly DA, Renehan AG. Excess adiposity and gastrointestinal cancer. Br J Surg. 2014;101:1518–31. discussion 31. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 CA016087/CA/NCI NIH HHS/United States
- R01 HL034595/HL/NHLBI NIH HHS/United States
- UM1 CA182934/CA/NCI NIH HHS/United States
- UM1 CA173640/CA/NCI NIH HHS/United States
- Z01 ES049030/ImNIH/Intramural NIH HHS/United States
- R01 CA039742/CA/NCI NIH HHS/United States
- UM1 CA182913/CA/NCI NIH HHS/United States
- R01 CA047988/CA/NCI NIH HHS/United States
- R01 HL080467/HL/NHLBI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R01 CA040360/CA/NCI NIH HHS/United States
- R01 CA034944/CA/NCI NIH HHS/United States
- R01 CA082729/CA/NCI NIH HHS/United States
- Z01 ES044005/ImNIH/Intramural NIH HHS/United States
- R01 HL043851/HL/NHLBI NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- P30 ES000002/ES/NIEHS NIH HHS/United States
- R37 CA070867/CA/NCI NIH HHS/United States
- K05 CA136967/CA/NCI NIH HHS/United States
- R01 CA098661/CA/NCI NIH HHS/United States
- R01 CA077398/CA/NCI NIH HHS/United States
- R01 HL026490/HL/NHLBI NIH HHS/United States
- UM1 CA182910/CA/NCI NIH HHS/United States
- RC1 HL099355/HL/NHLBI NIH HHS/United States
- R01 CA097193/CA/NCI NIH HHS/United States
- 001/WHO_/World Health Organization/International
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical